Skip to main content
SpringerLink
Log in
Book cover

Fertility Preservation and Restoration for Patients with Complex Medical Conditions pp 231–248Cite as

Polycystic Ovary Syndrome

  • Chapter
  • First Online:

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects almost 15% of women of reproductive age. As this disease is a syndrome, it affects different aspects of women health; it is much more prevalent in obese patients and affects different body systems leading to reproductive and metabolic complications. This chapter reviews different aspects of the disease, epidemiology, effect on menstrual cycle, hormonal implications, clinical manifestations, ultrasound findings, treatment options, and the effect on fertility. The goal is that all kind of physicians will achieve basic knowledge and will be able to diagnose this disease and derivate these patients to gynecologist and endocrinologist for correct treatment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Goodman NF et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1. Endocr Pract. 2015;21(11):1291–300.

    Article  PubMed  Google Scholar 

  2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434–8.

    CAS  PubMed  Google Scholar 

  3. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

    Article  Google Scholar 

  4. Azziz R et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.

    Article  PubMed  Google Scholar 

  5. Li R et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562–9.

    Article  PubMed  Google Scholar 

  6. Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013;31(5):365–9.

    Article  PubMed  Google Scholar 

  7. Kollmann M et al. Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod. 2015;30(10):2396–403.

    Article  CAS  PubMed  Google Scholar 

  8. Apridonidze T et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–35.

    Article  CAS  PubMed  Google Scholar 

  9. March WA et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–51.

    Article  PubMed  Google Scholar 

  10. Azziz R et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90(8):4650–8.

    Article  CAS  PubMed  Google Scholar 

  11. Wild RA. Long-term health consequences of POCS. Hum Reprod Update. 2002;8(3):231–41.

    Article  PubMed  Google Scholar 

  12. Norman RJ et al. Polycystic ovary syndrome. The Lancet. 2007;370(9588):685–97.

    Article  CAS  Google Scholar 

  13. Fauser BC et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38. e25.

    Google Scholar 

  14. Dumont A et al. Role of Anti-Mullerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol. 2015;13(1):137.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Day FR et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. de Wilde MA et al. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes. Hum Reprod. 2015;30(6):1447–53.

    Article  PubMed  Google Scholar 

  17. Corbett S, Morin-Papunen L. The polycystic ovary syndrome and recent human evolution. Mol Cell Endocrinol. 2013;373(1–2):39–50.

    Article  CAS  PubMed  Google Scholar 

  18. Dumesic DA et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrinol Metab. 2014;99(11):E2412–20.

    Article  CAS  PubMed  Google Scholar 

  20. Kosova G, Urbanek M. Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373(1–2):29–38.

    Article  CAS  PubMed  Google Scholar 

  21. Cui L et al. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature. Hum Reprod. 2015;30(3):732–6.

    Article  PubMed  Google Scholar 

  22. Dewailly D et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–85.

    Article  PubMed  Google Scholar 

  23. Vink JM et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–4.

    Article  CAS  PubMed  Google Scholar 

  24. Lee H et al. A genetic risk score is associated with polycystic ovary syndrome-related traits. Hum Reprod. 2016;31(1):209–15.

    Article  CAS  PubMed  Google Scholar 

  25. Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998;95:14956–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421–3.

    Article  PubMed  Google Scholar 

  27. Moran LJ et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.

    Article  CAS  PubMed  Google Scholar 

  28. Moran LJ et al. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012;27(7):2082–8.

    Article  CAS  PubMed  Google Scholar 

  29. Moran L et al. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol. 2010;31(1):24–31.

    Article  PubMed  Google Scholar 

  30. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS) Amsterdam Eshre Asrm-Sponsored 3rd Pcos Consensus Workshop Group. Hum Reprod. 2012;27(1):14–24.

    Google Scholar 

  31. Speroff L. Chronic anovulation and the polycystic ovary syndrome. In: Fritz MA, Speroff L, editors. Clinical gynecologic endocrinology and infertility: Lippinicott; 2008. p. 496–531.

    Google Scholar 

  32. Escobar-Morreale HF et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146–70.

    Article  CAS  PubMed  Google Scholar 

  33. Broekmans FJ et al. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006;113(10):1210–7.

    Article  CAS  PubMed  Google Scholar 

  34. Laven JS, Imani B, Eijkemans MJC, Fauser BCJ. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv. 2002;57(11):755–67.

    Article  PubMed  Google Scholar 

  35. Webber LJ et al. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362(9389):1017–21.

    Article  CAS  PubMed  Google Scholar 

  36. Maciel GA et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5321–7.

    Article  CAS  PubMed  Google Scholar 

  37. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):101–17.

    Article  Google Scholar 

  38. Beloosesky R et al. Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio. Int J Mol Med. 2004;14(2):207–15.

    CAS  PubMed  Google Scholar 

  39. Homburg R, Crawford G. The role of AMH in anovulation associated with PCOS: a hypothesis. Hum Reprod. 2014;29(6):1117–21.

    Article  CAS  PubMed  Google Scholar 

  40. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367–78.

    Article  CAS  PubMed  Google Scholar 

  41. Pigny P et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957–62.

    Article  CAS  PubMed  Google Scholar 

  42. Laven JS et al. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89(1):318–23.

    Article  CAS  PubMed  Google Scholar 

  43. Park AS et al. Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism. J Clin Endocrinol Metab. 2010;95(4):1786–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Dewailly D et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123–9.

    Article  CAS  PubMed  Google Scholar 

  45. Pellatt L et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92(1):240–5.

    Article  CAS  PubMed  Google Scholar 

  46. Catteau-Jonard S et al. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? Ultrasound Obstet Gynecol. 2012;40(2):223–9.

    Article  CAS  PubMed  Google Scholar 

  47. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9(6):505–14.

    Article  PubMed  Google Scholar 

  48. Group, G.W. Education and debate. BMJ. 2004;328:1–8.

    Article  Google Scholar 

  49. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod. 2003;18(3):598–603.

    Article  CAS  PubMed  Google Scholar 

  50. Johnstone EB et al. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010;95(11):4965–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand. 1999;78:137–41.

    Article  CAS  PubMed  Google Scholar 

  52. Polson DW et al. Polycystic ovaries-a common finding in normal women. Lancet. 1988;1(8590):870–2.

    Google Scholar 

  53. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.

    CAS  PubMed  Google Scholar 

  54. Boomsma CM et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–83.

    Article  CAS  PubMed  Google Scholar 

  55. Barber TM et al. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;66(4):513–7.

    CAS  Google Scholar 

  56. Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond). 2007;31(Suppl 2):S8–13. ; discussion S31-2.

    Article  Google Scholar 

  57. Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertil Steril. 2012;97(1):13–7.

    Article  PubMed  Google Scholar 

  58. Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30(6):496–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Lord J et al. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006;113(10):1203–9.

    Article  CAS  PubMed  Google Scholar 

  60. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–36.

    Article  CAS  PubMed  Google Scholar 

  61. Ehrmann DA et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):48–53.

    Article  CAS  PubMed  Google Scholar 

  62. Dunaif A et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74.

    Article  CAS  PubMed  Google Scholar 

  63. Zhao X et al. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2010;108(2):148–51.

    Article  CAS  PubMed  Google Scholar 

  64. Dokras A, CliftonS, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome a systematic review and meta-analysis. Obstet Gynecol. 2011;117(1):145–52.

    Article  PubMed  Google Scholar 

  65. de Niet JE et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod. 2010;25(6):1497–503.

    Article  PubMed  Google Scholar 

  66. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv. 2006;61(11):723–32.

    Article  PubMed  Google Scholar 

  67. Elsenbruch S et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(12):5801–7.

    Article  CAS  PubMed  Google Scholar 

  68. Jones GL et al. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2008;14(1):15–25.

    Article  CAS  PubMed  Google Scholar 

  69. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod. 2012;27(5):1327–31.

    Article  PubMed  Google Scholar 

  70. Chittenden B. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009;19(3):398–405.

    Article  CAS  PubMed  Google Scholar 

  71. Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782–5.

    Article  CAS  PubMed  Google Scholar 

  72. Group, E.C.W. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update. 2012;18(5):586–99.

    Article  Google Scholar 

  73. Dumesic DA, Padmanabhan V, Abbott DH. Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv. 2008;63(1):39–48.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Weghofer A et al. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril. 2007;88(4):900–5.

    Article  PubMed  Google Scholar 

  75. Alchami A, O'Donovan O, Davies M. PCOS: diagnosis and management of related infertility. Obstet Gynaecol Reprod Med. 2015;25(10):279–82.

    Article  Google Scholar 

  76. Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201 e1–5.

    Article  Google Scholar 

  77. Carreau AM, Baillargeon JP. PCOS in adolescence and type 2 diabetes. Curr Diab Rep. 2015;15(1):564.

    Article  PubMed  Google Scholar 

  78. Roe AH et al. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr. 2013;162(5):937–41.

    Article  PubMed  Google Scholar 

  79. Teede HJ et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195(6):S65–112.

    Article  PubMed  Google Scholar 

  80. Walls ML et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2015;30(1):88–96.

    Article  CAS  PubMed  Google Scholar 

  81. Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2012;98(4):888–92.

    Article  PubMed  Google Scholar 

  82. Lindenberg S. New approach in patients with polycystic ovaries, lessons for everyone. Fertil Steril. 2013;99(5):1170–2.

    Article  PubMed  Google Scholar 

  83. Ganor-Paz Y et al. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation. J Endocrinol Invest. 2016;39(7):799–803.

    Google Scholar 

  84. Costello MF, Ledger WL. Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology. Future Med. 2012;8(3):291–300.

    CAS  Google Scholar 

  85. Reindollar RH et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril. 2010;94(3):888–99.

    Article  PubMed  Google Scholar 

  86. Franks S. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clin Endocrinol (Oxf). 2011;74(2):148–51.

    Article  Google Scholar 

  87. Wild RA et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038–49.

    Article  CAS  PubMed  Google Scholar 

  88. Legro RS et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–92.

    Article  CAS  PubMed  Google Scholar 

  89. Bergh CM, Moore M, Gundell C. Evidence-based management of infertility in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2016;45(1):111–22.

    Article  PubMed  Google Scholar 

  90. Tang T et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;5:CD003053.

    Google Scholar 

  91. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subertility (Review). The Cochrane Library. 2010:1–135.

    Google Scholar 

  92. Romualdi D et al. Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Fertil Steril. 2010;93(7):2303–10.

    Article  CAS  PubMed  Google Scholar 

  93. Tang T, Balen AH. Use of metformin for women with polycystic ovary syndrome. Hum Reprod Update. 2013;19(1):1.

    Article  PubMed  Google Scholar 

  94. Chambers GM et al. Is in vitro fertilisation more effective than stimulated intrauterine insemination as a first-line therapy for subfertility? A cohort analysis. Aust N Z J Obstet Gynaecol. 2010;50(3):280–8.

    Article  PubMed  Google Scholar 

  95. Walls M et al. IVF versus ICSI for the fertilization of in-vitro matured human oocytes. Reprod Biomed Online. 2012;25(6):603–7.

    Article  CAS  PubMed  Google Scholar 

  96. El Hachem H et al. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol. 2014;30(6):415–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ann and Robert Lurie Children’s Hospital, Chicago, Illinois, USA

    Allison L. Goetsch

  2. Northwestern University, Chicago, Illinois, USA

    Dana Kimelman & Teresa K. Woodruff

Authors
  1. Allison L. Goetsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana Kimelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teresa K. Woodruff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Goetsch, A.L., Kimelman, D., Woodruff, T.K. (2017). Polycystic Ovary Syndrome. In: Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-52316-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52316-3_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52315-6

  • Online ISBN: 978-3-319-52316-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation